Human Genome Epidemiology Literature Finder
Records 1 - 19 (of 19 Records) |
Query Trace: Leukemia and EGFR[original query] |
---|
Clinical significance of BRAF gene mutations in patients with non-small cell lung cancer. Anticancer research 2011 Dec 31 (12): 12. Kobayashi M, Sonobe M, Takahashi T, Yoshizawa A, Ishikawa M, Kikuchi R, Okubo K, Huang CL, Date H |
Lung adenocarcinomas with HER2-activating mutations are associated with distinct clinical features and HER2/EGFR copy number gains. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012 Jan 7 (1): 85-9. Li Chenguang, Sun Yihua, Fang Rong, Han Xiangkun, Luo Xiaoyang, Wang Rui, Pan Yunjian, Hu Haichuan, Zhang Yang, Pao William, Shen Lei, Ji Hongbin, Chen Haiqu |
Analysis of the polymorphisms EGFR-r521K and ERBB2-I655V in Mexican patients with gastric cancer and premalignant gastric lesions. Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición 0 65 (2): 150-5. Torres-Jasso Juan Heriberto, Bustos-Carpinteyro Andrea Rebeca, Marín María Eugenia, Santiago Ernesto, Leoner Carlos, Flores-Luna Lourdes, Torres Javier, Sánchez-Lopez Josefina Yoa |
Detection of E2A-PBX1 fusion transcripts in human non-small-cell lung cancer. Journal of experimental & clinical cancer research : CR 2013 32 29. Mo Min-Li, Chen Zhao, Zhou Hai-Meng, Li Hui, Hirata Tomomi, Jablons David M, He Bi |
Multi-agent chemotherapy overcomes glucocorticoid resistance conferred by a BIM deletion polymorphism in pediatric acute lymphoblastic leukemia. PloS one 2014 9 (8): e103435. Soh Sheila Xinxuan, Lim Joshua Yew Suang, Huang John W J, Jiang Nan, Yeoh Allen Eng Juh, Ong S Tio |
The Bim deletion polymorphism clinical profile and its relation with tyrosine kinase inhibitor resistance in Chinese patients with non-small cell lung cancer. Cancer 2014 Aug 120 (15): 2299-307. Zhao Mingchuan, Zhang Yishi, Cai Weijing, Li Jiayu, Zhou Fei, Cheng Ningning, Ren Ruixin, Zhao Chao, Li Xuefei, Ren Shengxiang, Zhou Caicun, Hirsch Fred |
The effect of BIM deletion polymorphism on intrinsic resistance and clinical outcome of cancer patient with kinase inhibitor therapy. Scientific reports 2015 5 11348. Ying Hou-Qun, Chen Jie, He Bang-Shun, Pan Yu-Qin, Wang Feng, Deng Qi-Wen, Sun Hui-Ling, Liu Xian, Wang Shu-K |
Clinical features of Bim deletion polymorphism and its relation with crizotinib primary resistance in Chinese patients with ALK/ROS1 fusion-positive non-small cell lung cancer. Cancer 2017 Mar . Zhang Limin, Jiang Tao, Li Xuefei, Wang Yan, Zhao Chao, Zhao Sha, Xi Lei, Zhang Shijia, Liu Xiaozhen, Jia Yijun, Yang Hui, Shi Jinpeng, Su Chunxia, Ren Shengxiang, Zhou Caic |
EGFR-TKIs plus chemotherapy demonstrated superior efficacy than EGFR-TKIs alone as first-line setting in advanced NSCLC patients with EGFR mutation and BIM deletion polymorphism. Lung cancer (Amsterdam, Netherlands) 2018 Jun 120 82-87. Liu Sangtian, He Yayi, Jiang Tao, Ren Shengxiang, Zhou Fei, Zhao Chao, Li Xuefei, Zhang Jie, Su Chunxia, Chen Xiaoxia, Cai Weijing, Gao Guanghui, Li Wei, Wu Fengying, Li Jiayu, Zhao Jing, Hu Qiong, Zhao Mingchuan, Zhou Caicun, Hirsch Fred |
Discovery of donor genotype associated with long-term survival of patients with hematopoietic stem cell transplantation in refractory acute myeloid leukemia. Leukemia & lymphoma 2018 12 60 (7): 1775-1781. Ock Chan-Young, Seo Heewon, Kim Dae-Yoon, Min Byung Joo, Park Yoomi, Cheong Hyun Sub, Kim Hyung-Lae, Song Eun-Young, Kim Inho, Yoon Sung-Soo, Kim Ju Han, Koh Young |
Clinicopathological Significance of Common Genetic Alterations in Patients With Acute Promyelocytic Leukemia. Hematology/oncology and stem cell therapy 2020 8 15 (2): 54-57. Nath Sukanta, Bhattacharyya Jina, Chandra Prem, Saxena Renu, Sazawal Sudha, Saikia Kandarpa Kum |
Factors affecting high-grade hepatotoxicity of tyrosine kinase inhibitors in cancer patients: a multi-center observational study. European journal of clinical pharmacology 2020 May . Han Ji Min, Han Hye Won, Yee Jeong, Kim Min Kyoung, Moon Jin Young, Cho Soyeon, Jung Dasom, Cho Yoon Sook, Seo Inyoung, Kim Jae Youn, Gwak Hye S |
[Clinical analysis of 12 cases of acute myeloid leukemia complicated with synchronous primary solid tumor]. Zhonghua yi xue za zhi 2020 11 100 (42): 3323-3327. Mi R H, Dang H B, Chen L, Han Y L, Wang M F, Zhang Y L, Chen L, Li D B, Wei X |
Durable Response to Crizotinib in a Patient with Pulmonary Adenocarcinoma Harboring MET Intron 14 Mutation: A Case Report. OncoTargets and therapy 2021 7 14 3949-3958. Leyrat Brice, Durando Xavier, Veyssiere Hugo, Bernadach Maure |
Influence of Sex in the Molecular Characteristics and Outcomes of Malignant Tumors. Frontiers in oncology 2021 11 752918. Araujo Jhajaira M, Rosas Gina, Belmar-López Carolina, Raez Luis E, Rolfo Christian D, Schwarz Luis J, Infante-Huaytalla Ulises, Paez Kevin J, García Luis R, Alvarado Hober, Ramos Fany P, Delgado-Espinoza Sheyla S, Cardenas-Farfan Jhon B, Cornejo Melanie, Zanabria Daniel, Colonio-Cossio Christian, Rojas-Jefferson Mario, Pinto Joseph |
Exploration of Coding and Non-coding Variants in Cancer Using GenomePaint. Cancer cell 2021 1 39 (1): 83-95.e4. Zhou Xin, Wang Jian, Patel Jaimin, Valentine Marc, Shao Ying, Newman Scott, Sioson Edgar, Tian Liqing, Liu Yu, Brady Samuel W, Flasch Diane, Ma Xiaotu, Liu Yanling, Paul Robin, Edmonson Michael N, Rusch Michael C, Li Chunliang, Baker Suzanne J, Easton John, Zhang Jingh |
Causal Association between Chronic Kidney Disease and Risk of 19 Site-Specific Cancers: A Mendelian Randomization Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2022 3 31 (6): 1233-1242. Tang Lei, Li Chunyang, Chen Wenwen, Zeng Yu, Yang Huazhen, Hu Yao, Song Huan, Zeng Xiaoxi, Li Qiu, Fu Pi |
Effects of NRAS Mutations on Leukemogenesis and Targeting of Children With Acute Lymphoblastic Leukemia. Frontiers in cell and developmental biology 2022 2 10 712484. Qian Jiabi, Li Zifeng, Pei Kunlin, Li Ziping, Li Chunjie, Yan Muxia, Qian Maoxiang, Song Yuanbin, Zhang Hui, He Ying |
Systematic evaluation of clinical efficacy of CYP1B1 gene polymorphism in EGFR mutant non-small cell lung cancer observed by medical image. Open life sciences 2023 10 18 (1): 20220688. Shaofeng Zhang, Danqing Li, Xia H |
- Page last reviewed:Feb 1, 2024
- Content source: